Cargando…
Hypericin-mediated photodynamic therapy induces apoptosis in K562 human leukemia cells through JNK pathway modulation
Hypericin (Hyp) is traditionally used as an antidepressant and antiviral agent. It selectively accumulates in spheroids and is also used as a photosensitizer in the photodynamic therapy of cancer. The present study aimed to investigate the cytotoxic effect of Hyp-mediated photodynamic therapy (Hyp-P...
Autores principales: | XU, YIXIAO, WANG, DEXUAN, ZHUANG, ZHIZHI, JIN, KEKE, ZHENG, LVZHEN, YANG, QING, GUO, KUNYUAN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626167/ https://www.ncbi.nlm.nih.gov/pubmed/26330116 http://dx.doi.org/10.3892/mmr.2015.4258 |
Ejemplares similares
-
Hypericin-photodynamic therapy induces human umbilical vein endothelial cell apoptosis
por: Zhang, Qian, et al.
Publicado: (2015) -
Hypericin in the Dark: Foe or Ally in Photodynamic Therapy?
por: Huntosova, Veronika, et al.
Publicado: (2016) -
A photodynamic pathway to apoptosis and necrosis induced by dimethyl tetrahydroxyhelianthrone and hypericin in leukaemic cells: possible relevance to photodynamic therapy
por: Lavie, G, et al.
Publicado: (1999) -
Hypericin-photodynamic therapy inhibits the growth of adult T-cell leukemia cells through induction of apoptosis and suppression of viral transcription
por: Xu, Lingling, et al.
Publicado: (2019) -
Molecular profiling of angiogenesis in hypericin mediated photodynamic therapy
por: Bhuvaneswari, Ramaswamy, et al.
Publicado: (2008)